CoChat

Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Abstract

Amyotrophic lateral sclerosis (ALS) is a heterogeneous motor neuron disease for which no effective treatment is available, despite decades of research into SOD1-mutant familial ALS (FALS). The majority of ALS patients have no familial history, making the modeling of sporadic ALS (SALS) essential to the development of ALS therapeutics. However, as mutations underlying ALS pathogenesis have not yet been identified, it remains difficult to establish useful models of SALS. Using induced pluripotent stem cell (iPSC) technology to generate stem and differentiated cells retaining the patients' full genetic information, we have established a large number of in vitro cellular models of SALS. These models showed phenotypic differences in their pattern of neuronal degeneration, types of abnormal protein aggregates, cell death mechanisms, and onset and progression of these phenotypes in vitro among cases. We therefore developed a system for case clustering capable of subdividing these heterogeneous SALS models by their in vitro characteristics. We further evaluated multiple-phenotype rescue of these subclassified SALS models using agents selected from non-SOD1 FALS models, and identified ropinirole as a potential therapeutic candidate. Integration of the datasets acquired in this study permitted the visualization of molecular pathologies shared across a wide range of SALS models.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41591-018-0140-5

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 77 references

Cited by

See all 516

Metadata

Authors
Fujimori, K., Ishikawa, M., Otomo, A., Atsuta, N., Nakamura, R., Akiyama, T., Hadano, S., Aoki, M., Saya, H., Sobue, G., & Okano, H.
Affiliations
  • Keio University (JP)
  • Tokai University (JP)
  • Nagoya University (JP)
  • Tohoku University (JP)
Corresponding author
Okano, Hideyuki
Venue
Nature Medicine
Published
2018-08-20
Volume
24
Issue
10
Pages
1579-1589
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W2885306088
Cited by
494
References
77
Citations by year
2026: 29 · 2025: 39 · 2024: 57 · 2023: 47 · 2022: 169 · 2021: 65 · 2020: 62 · 2019: 22 · 2018: 4
FWCI
25.98
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science (17H01401, 16H05318, 17K16116, 26117002, 26117001, 26117007)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
sporadic ALS, induced pluripotent stem cells, motor neurons, iPSC-derived disease models, case clustering, neurodegeneration, protein aggregates, cell death mechanisms, ropinirole, molecular pathology
MeSH terms
Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Cell Differentiation, Humans, Indoles, Motor Neurons, Mutation, Nerve Degeneration, Phenotype, Induced Pluripotent Stem Cells, Protein Aggregation, Pathological

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. https://app.cochat.ai/papers/10.1038/s41591-018-0140-5
The paper
Fujimori, K., Ishikawa, M., Otomo, A., Atsuta, N., Nakamura, R., Akiyama, T., Hadano, S., Aoki, M., Saya, H., Sobue, G., & Okano, H. (2018). Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nature Medicine. https://doi.org/10.1038/s41591-018-0140-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.